If you’re one of the many to have used our online ranking of pharmaceutical companies, then you’ll already know what a wealth of information the Top Pharma List contains.
In this month’s PME we’ve got an inside look at some of the List’s newly updated figures as we present the key industry trends for 2018 and beyond.
We also hear from UCB’s Erik Janssen, who looks to what the future holds for his company and its quest for innovative solutions.
Meanwhile, Insmed’s Olaf Bartsch tells us about a year of progress at the US biotech and the challenges of working with a rare lung condition.
And Merck offers an insight into its PMEA winning eHealth innovation and how the work is improving outcomes for young patients by harnessing technology.
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
